DWTX — Dogwood Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Dogwood Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	29.8	14	7.03	3.32	14.8
Prepaid Expenses
Total Other Current Assets
Total Current Assets	31.5	15.8	8.37	4.17	16.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	—	—	0.223
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	31.5	15.8	8.37	4.17	94.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.53	1.28	1.04	0.359	3.18
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1.53	1.28	1.04	0.359	30
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	29.9	14.5	7.33	3.81	64.3
Total Liabilities & Shareholders' Equity	31.5	15.8	8.37	4.17	94.3
Total Common Shares Outstanding